Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection

Jessica Liu, Hui Han Hu, Chia Ling Chang, Chin Lan Jen, Mei Hsuan Lee, Sheng Nan Lu, Li Yu Wang, Quan Yuan, Ning Shao Xia, Masaya Sugiyama, Nao Nishida, Masashi Mizokami, Chien Jen Chen, Pei Jer Chen, Hwai I. Yang*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

10 Scopus citations

Abstract

For chronic hepatitis B patients, hepatitis B e antigen (HBeAg) seroclearance signals a transition from an immunologically active phase to an inactive carrier state with a reduction in hepatitis B virus (HBV) DNA levels and a reduced risk of hepatocellular carcinoma (HCC).1 Predictors of HBeAg seroclearance include lower HBV DNA levels, viral genotype, the precore mutation, and higher serum alanine aminotransferase (ALT) levels.2

Original languageEnglish
Pages (from-to)1413-1415
Number of pages3
JournalClinical Gastroenterology and Hepatology
Volume17
Issue number7
DOIs
StatePublished - Jun 2019

Fingerprint

Dive into the research topics of 'Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection'. Together they form a unique fingerprint.

Cite this